Prostate Ductal Adenocarcinoma

specific

A usually aggressive invasive adenocarcinoma of the prostate gland composed of large glands containing tall columnar cells. The columnar cells have abundant cytoplasm and are reminiscent of endometrial carcinoma. This type of adenocarcinoma has a tendency to metastasize to the lung and penis.

32

Centers

32

Active Trials

Cancer Funding

Top Centers for Prostate Ductal Adenocarcinoma(32)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
51.6
2
NCI Comprehensive
Active Research Program
51.6
3
NCI Comprehensive
Active Research Program
51.6
4
NCI Comprehensive
Active Research Program
51.6
5
NCI Comprehensive
Active Research Program
51.6
651.6
7
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
51.6
8
NCI Comprehensive
Active Research Program
51.6
9
NCI Comprehensive
Active Research Program
51.6
10
NCI Comprehensive
Active Research Program
51.6
11
NCI Comprehensive
Active Research Program
51.6
12
NCI Comprehensive
Active Research Program
51.6
13
NCI Comprehensive
Active Research Program
51.6
14
NCI Clinical
Active Research Program
51.6
15
NCI Comprehensive
Active Research Program
51.6
16
NCI Comprehensive
Active Research Program
51.6
17
Active Research Program
51.6
18
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
51.6
19
NCI Comprehensive
Active Research Program
51.6
20
NCI Clinical
Active Research Program
51.6
21
Active Research Program
51.6
22
NCI Comprehensive
Active Research Program
51.6
23
Active Research Program
51.6
24
NCI Comprehensive
Active Research Program
51.6
25
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
51.6
26
Active Research Program
51.6
27
Active Research Program
51.6
28
Active Research Program
51.6
29
Active Research Program
51.6
30
Active Research Program
51.6
31
Active Research Program
51.6
32
Active Research Program
51.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →